Dr. Emily Park
InvestorPrincipal, DCVC Bio at DCVC Bio
Find your path to Dr. Emily Park
17 people in our graph share verified history with Dr. Emily Park — schools, employers, funds. One of them is your warm intro.
About
Emily Park invests in early-stage therapeutics platform and computational biology companies at DCVC Bio, concentrating on drug development and pipeline strategy while advising portfolio companies on operations and fundraising. She previously worked in public markets as a biotech equities analyst at Point72 Asset Management and on Goldman Sachs' Global Investment Research team, and has consulted independently for hedge funds and TechBio companies. She holds a bachelor's degree in English literature from Columbia University and an MD from Rutgers New Jersey Medical School.
Invests in
AI & Machine LearningBiotech
Colleagues at DCVC Bio
Frequently asked questions
- Who is Dr. Emily Park?
- Emily Park invests in early-stage therapeutics platform and computational biology companies at DCVC Bio, concentrating on drug development and pipeline strategy while advising portfolio companies on operations and fundraising. She previously worked in public markets as a biotech equities analyst at Point72 Asset Management and on Goldman Sachs' Global Investment Research team, and has consulted independently for hedge funds and TechBio companies. She holds a bachelor's degree in English literature from Columbia University and an MD from Rutgers New Jersey Medical School.
- Where does Dr. Emily Park work?
- Dr. Emily Park is Principal, DCVC Bio at DCVC Bio.
- What does Dr. Emily Park invest in?
- Dr. Emily Park invests in AI & Machine Learning, Biotech.